0449 Unbiased Examination of Metabolomic Signatures in Sleep Disordered Breathing and Group 1 PAH in the (PVDOMICS) Cohort
Sign Up to like & getrecommendations! Published in 2023 at "SLEEP"
DOI: 10.1093/sleep/zsad077.0449
Abstract: Metabolic alterations have been identified as a novel driver of pulmonary arterial hypertension (PAH) pathogenesis. Sleep disordered breathing (SDB), characterized by intermittent hypoxemic episodes, has also been implicated in PAH, particularly when associated with more… read more here.
Keywords: metabolism; group pah; disordered breathing; sleep disordered ... See more keywords
THERAPEUTIC EFFECTS OF ALOPERINE ON THE PULMONARY ARTERIAL HYPERTENSION
Sign Up to like & getrecommendations! Published in 2019 at "FARMACIA"
DOI: 10.31925/farmacia.2019.4.19
Abstract: In order to study the therapeutic effect of aloperine (ALO) on the pulmonary arterial hypertension (PAH), 90 male Sprague Dawley (SD) rats were divided into six groups: sham group, PAH group, PAH + 25 mg/kg… read more here.
Keywords: pah; alo; pulmonary arterial; group pah ... See more keywords